Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.
about
Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees.SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsSystematic and transparent inclusion of ethical issues and recommendations in clinical practice guidelines: a six-step approachHow to write a systematic review of reasonsReciprocity-based reasons for benefiting research participants: most fail, the most plausible is problematic.Did we describe what you meant? Findings and methodological discussion of an empirical validation study for a systematic review of reasons.Canadian research ethics board members' attitudes toward benefits from clinical trials.Ethical issues in public health surveillance: a systematic qualitative review.Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastomaPost-trial accessIntroduction: the Fogarty International Research Ethics Education and Curriculum Development Program in historical contextThe potential exploitation of research participants in high income countries who lack access to health careEthical issues in HIV prevention research with people who inject drugs.Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments.Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research.Ethics Oversight Mechanisms for Surgical Innovation: A Systematic and Comparative Review of Arguments.Pharmaceutical companies vs. the State: who is responsible for post-trial provision of drugs in Brazil?Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare.Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research.QUALITY ASSESSMENT OF ETHICS ANALYSES FOR HEALTH TECHNOLOGY ASSSESSMENT.Post-trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation.Conscientious objection to participation in abortion by midwives and nurses: a systematic review of reasons.The ethics of uninsured participants accessing healthcare in biomedical research: A literature review
P2860
Q27316910-0E68D708-E0AE-42F6-B24D-43444F4D50E1Q28710019-83B3F90E-762B-4697-A310-B3D40BC34E70Q30607861-98E54747-7156-42A1-BC1C-6900BDF80BCAQ34073638-15B948E6-B59D-455A-9C89-7A3FA1E6E104Q34556648-009D7C22-C2F8-4D2A-B341-813E2AA52F2AQ35282065-43657FC1-38D3-485D-9DD7-B7FB3E5ABF0CQ35859372-9112CFFA-B92A-4A40-B1CE-E24319031931Q36334586-D9DB798C-EBB3-43CD-B118-95009593BCD8Q36589638-419012DB-28D9-43CC-ABC5-AB20768D215FQ36696784-3747C039-9C67-4DFD-97D1-B7E9BE8614C1Q36781288-021C8FB7-B839-43B2-A761-264676D849E2Q36806612-E2F0B8B2-9A28-489A-9ACD-8BF5A8DA9C5FQ37678502-05C5F048-0162-45E2-8858-A4D40A1B648DQ37703633-014A8163-2566-419A-9EDD-98A3C8C9C849Q38781965-5AB5CD61-20D8-49A9-B234-6F35DD56922BQ38872543-7282262B-FFBF-40F8-8D45-D60A8B254382Q39587226-06C7EBEF-3188-4112-98E6-72A57AC5E330Q45790569-FA67F23B-065F-46E7-83B2-4C7015455851Q46431772-C8389149-B989-4B38-8624-D7E8B7D9B94DQ47558308-2030BB60-5034-486C-A3BA-AF197BDB2B36Q47610929-BE1A76B0-BD00-49E5-92B9-F05DA2A6AED0Q47935627-1284A16C-F368-46E9-91AF-2C0C4506EDE4Q55004961-367F7692-E178-4654-8107-CD2781D70257Q58656949-0AFA5F9C-F2B0-4161-9749-3695125E8495
P2860
Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@ast
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@en
type
label
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@ast
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@en
prefLabel
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@ast
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@en
P2860
P356
P1433
P1476
Reasons Why Post-Trial Access ...... icipants: A Systematic Review.
@en
P2093
Neema Sofaer
P2860
P304
P356
10.1093/PHE/PHR013
P577
2011-07-11T00:00:00Z